Jan 30 (Reuters) - The following are the top stories in
the Financial Times. Reuters has not verified these stories and
does not vouch for their accuracy.
Headlines
- RQ Bio partners with AstraZeneca in COVID antibody fight
- Nuclear industry calls for new UK reactors as 'matter of
priority'
- Rio Tinto apologises for losing highly radioactive capsule
- BP cuts long-term forecast for oil and gas demand
Overview
- AstraZeneca moved to bolster its COVID-19
portfolio of antibodies with a $157 million licensing deal for
experimental therapies developed by newly-launched biotech RQ
Bio.
- UK ministers are under pressure to launch a government
agency to develop a new fleet of nuclear reactors in Britain "as
a matter of a priority".
- Rio Tinto Ltd's iron ore division chief Simon
Trott apologised after a contractor hired by the mining giant
lost a radioactive capsule in transit in Western Australia which
sparked a radiation alert across parts of the state.
- Russia's war in Ukraine is expected to weigh on long-term
energy demand and accelerate the world's shift to renewables and
low-carbon power as countries boost domestic energy supplies, BP said.
(Compiled by Bengaluru newsroom)
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.